Lavaca Capital LLC Eli Lilly & CO Transaction History

Lavaca Capital LLC

$233 Million
Q3 2024

A detailed history of Lavaca Capital LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Lavaca Capital LLC holds 1,200 shares of LLY stock, worth $919,920. This represents 0.46% of its overall portfolio holdings.

Number of Shares

1,200

Previous 1,199 0.08%

Holding current value

$919,920

Previous $1.09 Million 2.03%

% of portfolio

0.46%

Previous 0.56%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$772.14 - $960.02 $772 - $960	1 Added 0.08%	1,200 $1.06 Million
Q2 2024 Aug 13, 2024	BUY	$724.87 - $909.04 $724 - $909	1 Added 0.08%	1,199 $1.09 Million
Q1 2024 May 15, 2024	SELL	$592.2 - $792.28 $1.04 Million - $1.39 Million	-1,754 Reduced 59.42%	1,198 $931,000
Q4 2023 Feb 14, 2024	SELL	$525.19 - $619.13 $30,461 - $35,909	-58 Reduced 1.93%	2,952 $1.72 Million
Q3 2023 Nov 13, 2023	SELL	$434.7 - $599.3 $71,290 - $98,285	-164 Reduced 5.17%	3,010 $1.62 Million
Q2 2023 Aug 25, 2023	BUY	$350.74 - $468.98 $1.11 Million - $1.49 Million	3,174 New	3,174 $1.49 Million
Q1 2023 May 15, 2023	SELL	$310.63 - $364.82 $30,131 - $35,387	-97 Reduced 2.89%	3,258 $1.12 Million
Q4 2022 Feb 14, 2023	SELL	$321.55 - $374.67 $47,589 - $55,451	-148 Reduced 4.22%	3,355 $1.23 Million
Q3 2022 Nov 14, 2022	SELL	$296.48 - $337.87 $589,402 - $671,685	-1,988 Reduced 36.2%	3,503 $1.13 Million
Q2 2022 Aug 12, 2022	SELL	$278.73 - $327.27 $110,655 - $129,926	-397 Reduced 6.74%	5,491 $1.78 Million
Q1 2022 May 13, 2022	SELL	$234.69 - $291.66 $1.77 Million - $2.2 Million	-7,548 Reduced 56.18%	5,888 $1.69 Million
Q4 2021 Feb 10, 2022	SELL	$224.85 - $279.04 $44,520 - $55,249	-198 Reduced 1.45%	13,436 $3.71 Million
Q3 2021 Nov 12, 2021	BUY	$221.6 - $272.71 $221 - $272	1 Added 0.01%	13,634 $3.15 Million
Q2 2021 Aug 13, 2021	BUY	$180.55 - $233.54 $1.48 Million - $1.91 Million	8,180 Added 150.01%	13,633 $3.13 Million
Q1 2021 May 14, 2021	BUY	$164.32 - $212.72 $434,626 - $562,644	2,645 Added 94.2%	5,453 $1.02 Million
Q4 2020 Jan 13, 2021	SELL	$130.46 - $172.63 $637,558 - $843,642	-4,887 Reduced 63.51%	2,808 $474,000
Q3 2020 Nov 10, 2020	BUY	$146.22 - $169.13 $1.13 Million - $1.3 Million	7,695 New	7,695 $1.14 Million
Q2 2019 Jul 29, 2019	SELL	$110.79 - $129.32 $11,079 - $12,932	-100 Closed	0 $0
Q4 2018 Jan 22, 2019	BUY	$105.9 - $118.64 $10,590 - $11,864	100 New	100 $12,000

Others Institutions Holding LLY

# of Institutions

4,031

Shares Held

739M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $728B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lavaca Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lavaca Capital LLC with notifications on news.

Account

Lavaca Capital LLC Eli Lilly & CO Transaction History